These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20190288)

  • 1. Higher red blood cell distribution width is associated with the metabolic syndrome: results of the Ibermutuamur CArdiovascular RIsk assessment study.
    Sánchez-Chaparro MA; Calvo-Bonacho E; González-Quintela A; Cabrera M; Sáinz JC; Fernández-Labandera C; Aguado LQ; Meseguer AF; Valdivielso P; Román-García J;
    Diabetes Care; 2010 Mar; 33(3):e40. PubMed ID: 20190288
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population.
    Ascaso JF; Millán J; Mateo-Gallego R; Ruiz A; Suarez-Tembra M; Borrallo RM; Zambon D; Gonzalez-Santos P; Peres-de-Juan M; Ros E;
    Eur J Intern Med; 2011 Apr; 22(2):177-81. PubMed ID: 21402249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MetS and cardiovascular risk factors among Palestinians of East Jerusalem.
    Abu Sham'a RA; Darwazah AK; Kufri FH; Yassin IH; Torok NI
    East Mediterr Health J; 2009; 15(6):1464-73. PubMed ID: 20218139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population.
    Kelishadi R; Gharipour M; Sadri GH; Tavasoli AA; Amani A
    East Mediterr Health J; 2008; 14(5):1070-9. PubMed ID: 19161079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in obesity related cardiovascular risk factors in Spain.
    Cordero A; León M; Andrés E; Ordoñez B; Laclaustra M; Grima A; Pascual I; Luengo E; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Prev Med; 2009 Feb; 48(2):134-9. PubMed ID: 19038283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Bascaran MT; Martínez A S; Benabarre A; Sierra P; Torres P; Montes JM; Bousoño M; Bobes J;
    J Affect Disord; 2009 Jun; 115(3):302-8. PubMed ID: 18954911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components.
    Babio N; Bulló M; Basora J; Martínez-González MA; Fernández-Ballart J; Márquez-Sandoval F; Molina C; Salas-Salvadó J;
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):563-70. PubMed ID: 19176282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
    Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study.
    Pitsavos C; Panagiotakos DB; Skoumas J; Papadimitriou L; Stefanadis C
    Angiology; 2008; 59(3):335-41. PubMed ID: 18388068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.
    Hu G; Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Pyorala K;
    Arch Intern Med; 2004 May; 164(10):1066-76. PubMed ID: 15159263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
    Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
    Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of malnutrition and associated metabolic risk factors for cardiovascular disease in older adults from Northwest Mexico.
    Alemán-Mateo H; Esparza-Romero J; Romero RU; García HA; Pérez Flores FA; Ochoa Chacón BV; Valencia ME
    Arch Gerontol Geriatr; 2008; 46(3):375-85. PubMed ID: 17597234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between high red blood cell distribution width and metabolic syndrome. Influence of abdominal obesity.
    Vayá A; Carmona P; Badia N; Hernandez-Mijares A; Bautista D
    Clin Hemorheol Microcirc; 2011; 47(1):75-7. PubMed ID: 21321411
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
    Brunero S; Lamont S; Fairbrother G
    Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
    Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J
    Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.